Turgut Seckin Gul

Rational drug design for Alzheimer's disease: from approved therapies to next-generation clinical candidates and AI-guided innovation.

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by multifactorial pathology, including amyloid-β (Aβ) aggregation, tau hyperphosphorylation, oxidative stress, neuroinflammation, and synaptic dysfunction. Despite extensive research, currently approved treatment provides only symptomati...